ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.85
-0.28%
US Tech 100
21,009.20
1.28%
S&P 500
5,975.38
0.55%
US Dollar vs CAD
1.43311
-0.76%
Bitcoin
101,656.03
3.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Craven House Capital Plc (CRV) Share Price

Craven House Capital Plc

Craven House Capital Plc (CRV)

Cresval Capital Corp
0.25
0.00
(0.00%)
Closed January 06 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.25
Bid
0.20
Ask
0.30
Volume
215
0.25 Day's Range 0.278
0.125 52 Week Range 0.35
Market Cap
965.898k
Previous Close
0.25
Open
0.25
Last Trade
215
@
0.256
(UT)
Last Trade Time
Financial Volume
US$ 55
VWAP
0.256
Average Volume (3m)
1,704
Shares Outstanding
3,863,590
Dividend Yield
-
PE Ratio
-0.18
Earnings Per Share (EPS)
-1.43
Revenue
-5.26M
Net Profit
-5.52M

About Craven House Capital Plc

Sector
Finance Services
Industry
Finance Services
Website
www.cravenhousecapital.com
Headquarters
London, Gbr
Founded
-
Craven House Capital Plc is listed in the Finance Services sector of the London Stock Exchange with ticker CRV. The last closing price for Craven House Capital was US$0.25. Over the last year, Craven House Capital shares have traded in a share price range of US$ 0.125 to US$ 0.35.

Craven House Capital currently has 3,863,590 shares outstanding. The market capitalization of Craven House Capital is US$965,897.50 . Craven House Capital has a price to earnings ratio (PE ratio) of -0.18.

Ask ADVFN Intelligence (AI)

CRV Latest News

More News

Craven House Capital PLC Result of AGM

Craven House Capital PLC 16 December 2024   16 December 2024   Craven House Capital plc ("Craven House" or the "Company") Result of Annual General Meeting   Craven House Capital (AIM:CRV) is...

December 16 2024
RNS Regulatory News

Craven House Capital loss narrows due to fair value of investments

Craven House Capital PLC on Friday said its loss narrowed during its most recent financial year, as it also narrows i ...

November 15 2024
Alliance News

Craven House Capital PLC Annual Results For Year Ended 31 May 2024

Craven House Capital PLC 15 November 2024       Craven House Capital Annual Results For Year Ended 31 May 2024   Craven House Capital PLC 15 November 2024      THIS ANNOUNCEMENT CONTAINS...

November 15 2024
RNS Regulatory News

Craven House Capital PLC Investee company update: RoseMonkey Ltd

Craven House Capital PLC 10 September 2024   Craven House Capital PLC 10 September 2024 Certain information contained within this Announcement is deemed by the Company to constitute inside...

September 10 2024
RNS Regulatory News

Craven House Capital PLC TR-1: Notification of major holdings

Craven House Capital PLC 27 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD4FQ360 Issuer Name CRAVEN HOUSE CAPITAL PLC UK or Non-UK Issuer...

August 27 2024
RNS Regulatory News

Craven House Capital PLC TR-1: notification of major holdings

Craven House Capital PLC 23 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD4FQ360 Issuer Name CRAVEN HOUSE CAPITAL PLC UK or Non-UK Issuer...

August 23 2024
RNS Regulatory News

Craven House Capital PLC Investee Companies' Update: Bio Vitos

Craven House Capital PLC 05 June 2024   Craven House Capital PLC 5 June 2024   Certain information contained within this Announcement is deemed by the Company to constitute inside information...

June 05 2024
RNS Regulatory News

EARNINGS: Hutchmed revenue surges, Craven House's loss widens

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

February 28 2024
Alliance News

Craven House Capital PLC Interim Results

Craven House Capital PLC 28 February 2024   28 February 2024                               THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE...

February 28 2024
RNS Regulatory News

Craven House Capital PLC Result of Annual General Meeting

Craven House Capital PLC 04 January 2024 Craven House Capital plc ("Craven House" or the "Company") Result of Annual General Meeting Craven House Capital (AIM:CRV) is pleased...

January 04 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.250.2780.254280.25DE
4000.250.2780.251360.25DE
120.05250.20.2780.19517040.22735556DE
260.05250.20.350.1746790.24182641DE
520.166.66666666670.150.350.12525220.23884864DE
156000.250.5750.0714090.20764493DE
260-1.8-87.80487804882.056.050.0713260.52798047DE

CRV - Frequently Asked Questions (FAQ)

What is the current Craven House Capital share price?
The current share price of Craven House Capital is US$ 0.25
How many Craven House Capital shares are in issue?
Craven House Capital has 3,863,590 shares in issue
What is the market cap of Craven House Capital?
The market capitalisation of Craven House Capital is USD 965.9k
What is the 1 year trading range for Craven House Capital share price?
Craven House Capital has traded in the range of US$ 0.125 to US$ 0.35 during the past year
What is the PE ratio of Craven House Capital?
The price to earnings ratio of Craven House Capital is -0.18
What is the cash to sales ratio of Craven House Capital?
The cash to sales ratio of Craven House Capital is -0.18
What is the reporting currency for Craven House Capital?
Craven House Capital reports financial results in USD
What is the latest annual turnover for Craven House Capital?
The latest annual turnover of Craven House Capital is USD -5.26M
What is the latest annual profit for Craven House Capital?
The latest annual profit of Craven House Capital is USD -5.52M
What is the registered address of Craven House Capital?
The registered address for Craven House Capital is 776-778 BARKING ROAD, LONDON, E13 9PJ
What is the Craven House Capital website address?
The website address for Craven House Capital is www.cravenhousecapital.com
Which industry sector does Craven House Capital operate in?
Craven House Capital operates in the FINANCE SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
3.25p
(103.13%)
12.18M
BORBorders & Southern Petroleum Plc
3.64p
(51.04%)
23.81M
NEONeo Energy Metals Plc
0.95p
(22.58%)
37.84M
GNIPGenip Plc
32.00p
(20.75%)
192.82k
ZIOCZanaga Iron Ore Company Limited
10.50p
(19.86%)
2.84M
DGIDg Innovate Plc
0.02p
(-20.00%)
298.54M
SNGSynairgen Plc
2.10p
(-19.39%)
1.67M
VRSVersarien Plc
0.03p
(-18.92%)
103.72M
QEDQuadrise Plc
5.90p
(-17.83%)
17.66M
ZENZenith Energy Ltd.
4.90p
(-16.24%)
1.48M
SYMESupply@me Capital Plc
0.0042p
(12.00%)
1.19B
MSMNMosman Oil And Gas Limited
0.035p
(12.90%)
654.48M
TRPTower Resources Plc
0.0395p
(0.00%)
570.56M
CPXCap-xx Limited
0.1775p
(-2.74%)
379.2M
NTVONativo Resources Plc
0.0019p
(-5.00%)
312.89M

Discussion

View Full Feed
Wrangler1 Wrangler1 1 minute ago
Waste of time. He spoke as usual a lot of big words but said very little. the stock tomorrow will not move just as I predicted. complete nonsense. 
WDLF
Hello Newman Hello Newman 1 minute ago
Whatever happened to Pharma Sleuth?
ELTP
PennMilitia PennMilitia 2 minutes ago
Brad there is no recap here

For your information the GOVT wants to monetize their holdings in these companies - whether they are able to do that or not is still in question. Furthermore it has nothing to do with a recap - your out in left field with that one.

Also forg
FNMA
RKMKE RKMKE 2 minutes ago
What was exciting in this podcast and i can see nothing in the future as well...Just my opinion..
WDLF
go seek go seek 2 minutes ago
DD, you probably have enough shares to initiate a takeover! 😉
ENTA
boi568 boi568 3 minutes ago
There's every chance that Anavex will be seeking an FDA approval based on the regular schedule rather than accelerated approval. This new draft guidance is another step in the direction the FDA had already been signaling for the use of surrogate endpoints, and is not a surprise either to us or to th
AVXL
Investor2014 Investor2014 3 minutes ago
I never have and never will short any stock.
AVXL
Flobewan Flobewan 3 minutes ago
I'll put the bite right on those libtards
https://investorshub.advfn.com/uimage/uploads/2025/1/6/xqwyuPeanut_MAGA_Hat_6_Jan_2026_(Small).jpg
Slim6 Slim6 4 minutes ago
Wow, 500 million shares have been diluted to over 650 million shares. This company would be bk if they didn't dupe more bagholders to support their continued losses. RBLX is looking worse than ever, increasing losses to over $1 billion per year. Tangible book value is already 0.
RBLX
LexTrader LexTrader 5 minutes ago
Regulations are going to be overturned. Get it?
TGLO
Smartypants2 Smartypants2 5 minutes ago
It may seem like they haven't had their ducks in a row. But that may not be the only explanation. Sometimes slow and steady wins the race -- although it can drive retail investors crazy. The way I look at it, XERI is taking a very deliberate (if not agonizingly slow) approach to the research & devel
XERI
aBeezlee aBeezlee 5 minutes ago
The spectrum could have a lot of value long term, but as of today not going to do much for sp I think. Not until its purpose is announced. Like will it be for Google, DoD etc.
ASTS
PEACHMAN PEACHMAN 5 minutes ago
Kitty,there is never any excuse for telling lies about IFUS

You know the pps of IFUS will continue to rise as revenues and sales increase in 2025 and 2026.

New IFUS shareholders should do their own due diligence and ignore paid bashers.

just sayin
IFUS
rbl100 rbl100 5 minutes ago
What made this jump ? I see no reason for it.
BOXL
3jack 3jack 5 minutes ago
You should do some major shorting of this stock, if that’s what you truly believe.
AVXL
Richie Rich Richie Rich 5 minutes ago
I"ve been calling the office number and no one answers. I've called on different days.
PCTL
Lime Time Lime Time 6 minutes ago
More like .02 to .20
GVSI
Konaploinks Konaploinks 6 minutes ago
Soon 50. anything will be a gift. I said this at 10. 20. 30. and 40. Way more to come. I’d like to see a 2 for 1 forward split at 100.00. What you guys think?
IONQ
Gmenfan Gmenfan 7 minutes ago
Carville, like most Democrats, deludes himself about why Democrats lost the election

By Jack Hellner

James Carville said the Democrats would have won the election in a landslide if they would have disposed of Biden a year earlier.

According to The Hill:
threewheeler threewheeler 7 minutes ago
KRTL about to launch big time KRTLBIOTECH OTC:KRTL
@KRTLBiotech
“Congratulations $KRTL shareholders: We have successfully completed an acquisition and finalized a joint venture, both with FDA-registered manufacturers. Official press releases will be issued later this week. More to come
KRTL
Drugdoctor Drugdoctor 7 minutes ago
You mean back to .02 like $WNFT very soon... Thanks for the confidence.
WNFT
Gmenfan Gmenfan 7 minutes ago
Carville, like most Democrats, deludes himself about why Democrats lost the election

By Jack Hellner

James Carville said the Democrats would have won the election in a landslide if they would have disposed of Biden a year earlier.

According to The Hill:
Investor2014 Investor2014 7 minutes ago
You again serve up a complete non sequitur reply.
AVXL
threewheeler threewheeler 7 minutes ago
KRTL about to launch big time KRTLBIOTECH OTC:KRTL
@KRTLBiotech
“Congratulations $KRTL shareholders: We have successfully completed an acquisition and finalized a joint venture, both with FDA-registered manufacturers. Official press releases will be issued later this week. More to come
KRTL

Your Recent History

LSE
CRV
Craven House Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads